Prevention of endometrial hyperplasia by progesterone during long-term estradiol replacement: influence of bleeding pattern and secretory changes

This publication has 14 references indexed in Scilit:

• Progestagen supplementation of exogenous oestrogens and risk of endometrial cancer
  The Lancet, 1991
• Consensus development conference: prophylaxis and treatment of osteoporosis
  The American Journal of Medicine, 1991
• Inhibition of coronary artery atherosclerosis by 17-beta estradiol in ovariectomized monkeys. Lack of an effect of added progesterone.
  Arteriosclerosis: An Official Journal of the American Heart Association, Inc., 1990
• Compliance considerations with estrogen replacement: Withdrawal bleeding and other factors
  American Journal of Obstetrics and Gynecology, 1989
• Endometrial cancer and patterns of use of oestrogen replacement therapy: a cohort study
  British Journal of Cancer, 1989
• The effect of percutaneous estradiol and natural progesterone on postmenopausal bone loss
  American Journal of Obstetrics and Gynecology, 1987
• A Simple Method for Determining the Optimal Dosage of Progestin in Postmenopausal Women Receiving Estrogens
  New England Journal of Medicine, 1986
• Prevention of endometrial cancer with progestogens
  Maturitas, 1986
• Endometrial disease after treatment with oestrogens and progestogens in the climacteric.
  BMJ, 1980
• Estrogens and Endometrial Cancer in a Retirement Community
  New England Journal of Medicine, 1976